Larotrectinib sulfate
99%
- Product Code: 110244
CAS:
1223405-08-0
| Molecular Weight: | 526.51 g./mol | Molecular Formula: | C₂₁H₂₄F₂N₆O₆S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Larotrectinib sulfate is primarily used in the treatment of cancers that are caused by specific genetic mutations, particularly those involving NTRK gene fusions. It is effective in targeting and inhibiting the activity of TRK proteins, which are involved in the growth and spread of cancer cells. This medication is approved for use in both pediatric and adult patients, making it a versatile option for a wide range of ages. It is particularly beneficial for patients with solid tumors that have no other effective treatment options. The drug is administered orally, providing a convenient treatment method for patients. Common side effects include fatigue, nausea, dizziness, and increased liver enzymes, but it is generally well-tolerated. Larotrectinib sulfate represents a significant advancement in precision medicine, offering hope for patients with rare and difficult-to-treat cancers.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Yellow Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿5,000.00 |
+
-
|
| 1.000 | 10-20 days | ฿30,000.00 |
+
-
|
Larotrectinib sulfate
Larotrectinib sulfate is primarily used in the treatment of cancers that are caused by specific genetic mutations, particularly those involving NTRK gene fusions. It is effective in targeting and inhibiting the activity of TRK proteins, which are involved in the growth and spread of cancer cells. This medication is approved for use in both pediatric and adult patients, making it a versatile option for a wide range of ages. It is particularly beneficial for patients with solid tumors that have no other effective treatment options. The drug is administered orally, providing a convenient treatment method for patients. Common side effects include fatigue, nausea, dizziness, and increased liver enzymes, but it is generally well-tolerated. Larotrectinib sulfate represents a significant advancement in precision medicine, offering hope for patients with rare and difficult-to-treat cancers.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :